Chronic diffuse liver diseases (CDLD) of various etiologies remain a serious socio-economic and clinical-epidemiological health problem. Every year more than 1 million people die from cirrhosis of the liver of various etiology all over the world. According to the results of a study by a group of authors, it was found that in the Siberian Federal District there is an unfavorable situation in terms of gastroenterological mortality, in particular, hepatological mortality. CCM is characterized by lengthening of the QT interval, electromechanical dyssynchronization, and chronotropic insufficiency. The duration of the QTc interval in the subgroup of patients with liver cirrhosis who received basic therapy and the drug lisinopril (Diroton) was (418.21 ± 2.74 ms) and was significantly lower than in the subgroup of patients receiving only basic therapy. Evaluating the parameters of transthoracic echocardiography among patients with liver cirrhosis, it was noted that during treatment with basic drugs in combination with lisinopril (Diroton), the volume of LV EDV significantly decreased (p < 0.05). The appointment of an ACE inhibitor lisinopril to patients with cirrhosis of the liver as part of complex therapy leads to an improvement in general well-being, a decrease in shortness of breath, an increase in exercise tolerance, an improvement in basic laboratory parameters, as well as an improvement in some morphometric parameters (EDV) and cardiac electrical systole.
Aim. To study clinical and laboratory parameters that determine the unfavorable outcome of the disease among patients with cirrhosis of the liver. Materials and methods. The study involved 124 patients with cirrhosis of the liver, 64-the main group, among which a fatal outcome was recorded and 60 people with a favorable outcome of the disease. All patients underwent a complete clinical and laboratory study. Research result. The study revealed that predictors of an unfavorable outcome of liver cirrhosis are: previous alcoholism, non-compliance with recommended treatment measures, late medical treatment, overweight, more pronounced indicators of hepatic cell failure, cytolysis, as well as more pronounced anemia, hypoproteinemia, coagulopathy and higher creatinine levels. Conclusion. Clinical and laboratory indicators that can be used as predictors of an unfavorable outcome of liver cirrhosis were identified.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.